Intraperitoneally Delivered Mesenchymal Stem Cells Alleviate Experimental Colitis Through THBS1-Mediated Induction of IL-10-Competent Regulatory B Cells

Mesenchymal stem cells (MSCs) show promising therapeutic potential in treating inflammatory bowel disease (IBD), and intraperitoneal delivery of MSCs have become a more effective route for IBD treatment. However, the underlying mechanisms are still poorly understood. Here, we found that intraperiton...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jialing, Lai, Xingqiang, Bao, Yingying, Xie, Wenfeng, Li, Zhishan, Chen, Jieying, Li, Gang, Wang, Tao, Huang, Weijun, Ma, Yuanchen, Shi, Jiahao, Zhao, Erming, Xiang, Andy Peng, Liu, Qiuli, Chen, Xiaoyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971528/
https://www.ncbi.nlm.nih.gov/pubmed/35371051
http://dx.doi.org/10.3389/fimmu.2022.853894

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971528/
https://www.ncbi.nlm.nih.gov/pubmed/35371051
http://dx.doi.org/10.3389/fimmu.2022.853894

Ejemplares similares